(Q54002083)

23 May 2018

title

Sensitization of human malignant glioma cell lines to tumor necrosis factor-induced apoptosis by cisplatin. (English)

1 reference

23 May 2018

author name string

L Duan

1

1 reference

23 May 2018

M Aoyagi

2

1 reference

23 May 2018

M Tamaki

3

1 reference

23 May 2018

K Nakagawa

4

1 reference

23 May 2018

G Nagashima

5

1 reference

23 May 2018

Y Nagasaka

6

1 reference

23 May 2018

K Ohno

7

1 reference

23 May 2018

K Yamamoto

8

1 reference

23 May 2018

K Hirakawa

9

1 reference

23 May 2018

publication date

1 March 2001

1 reference

23 May 2018

Journal of Neuro-Oncology

published in

1 reference

23 May 2018

volume

52

1 reference

23 May 2018

issue

1

1 reference

23 May 2018

page(s)

23-36

1 reference

23 May 2018

https://scigraph.springernature.com/pub.10.1023/a:1010685110862

exact match

0 references

cites work

Tumor necrosis factor: specific binding and internalization in sensitive and resistant cells

1 reference

12 December 2020

Targeted toxin therapy for malignant astrocytoma

1 reference

12 December 2020

FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis

1 reference

12 December 2020

Fundamental studies with cisplatin

1 reference

12 December 2020

The TNF receptor 1-associated protein TRADD signals cell death and NF-kappa B activation

1 reference

12 December 2020

Overcoming cis-diamminedichloroplatinum (II) resistance of human ovarian tumor cells by combination treatment with cis-diamminedichloroplatinum (II) and tumor necrosis factor-alpha

1 reference

12 December 2020

Suppression of TNF-alpha-induced apoptosis by NF-kappaB

1 reference

12 December 2020

Resection, biopsy, and survival in malignant glial neoplasms. A retrospective study of clinical parameters, therapy, and outcome

1 reference

12 December 2020

Tumor necrosis factor's cytotoxic activity is signaled by the p55 TNF receptor

1 reference

12 December 2020

Activation of SAPK/JNK by TNF receptor 1 through a noncytotoxic TRAF2-dependent pathway

1 reference

12 December 2020

Therapy for patients with high grade astrocytoma using intraarterial chemotherapy and radiation therapy.

1 reference

12 December 2020

A novel protein that interacts with the death domain of Fas/APO1 contains a sequence motif related to the death domain

1 reference

12 December 2020

A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor

1 reference

12 December 2020

Involvement of the mitochondrion respiratory chain in the synergy achieved by treatment of human ovarian carcinoma cell lines with both tumor necrosis factor-alpha and cis-diamminedichloroplatinum

1 reference

12 December 2020

Brain tumors. Part 2.

1 reference

12 December 2020

Phase I clinical trial of recombinant human tumor necrosis factor in children with refractory solid tumors: a Pediatric Oncology Group study

1 reference

12 December 2020

Boron neutron-capture therapy (BNCT) for glioblastoma multiforme (GBM) using the epithermal neutron beam at the Brookhaven National Laboratory.

1 reference

12 December 2020

Cytostatic and cytotoxic activity of tumor necrosis factor on human cancer cells

1 reference

12 December 2020

Apoptotic, non-apoptotic, and anti-apoptotic pathways of tumor necrosis factor signalling

1 reference

12 December 2020

A novel domain within the 55 kd TNF receptor signals cell death

1 reference

12 December 2020

Clinical effect of intra-arterial tumor necrosis factor-alpha for malignant glioma

1 reference

12 December 2020

Sensitization of immunoresistant prostate carcinoma cell lines to Fas/Fas ligand-mediated killing by cytotoxic lymphocytes: independence of de novo protein synthesis.

1 reference

12 December 2020

Antitumor effect of tumor necrosis factor against various primarily cultured human cancer cells

1 reference

12 December 2020

Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells.

1 reference

12 December 2020

Cytotoxic mechanism of tumor necrosis factor-alpha

1 reference

12 December 2020

Purification and partial amino acid sequence analysis of two distinct tumor necrosis factor receptors from HL60 cells

1 reference

12 December 2020

A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins

1 reference

12 December 2020

Analysis of events associated with cell cycle arrest at G2 phase and cell death induced by cisplatin

1 reference

12 December 2020

Human glioblastoma cells release interleukin 6 in vivo and in vitro

1 reference

12 December 2020

X-ray structure of the major adduct of the anticancer drug cisplatin with DNA: cis-[Pt(NH3)2(d(pGpG))]

1 reference

12 December 2020

Manganous superoxide dismutase is essential for cellular resistance to cytotoxicity of tumor necrosis factor

1 reference

12 December 2020

Role of DNA repair in the mechanisms of cell resistance to alkylating agents and cisplatin

1 reference

12 December 2020

TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex

1 reference

12 December 2020

Nuclear factor kB-independent cytoprotective pathways originating at tumor necrosis factor receptor-associated factor 2

1 reference

12 December 2020

Sensitivity of resistant human tumor cell lines to tumor necrosis factor and adriamycin used in combination: correlation between down-regulation of tumor necrosis factor-messenger RNA induction and overcoming resistance

1 reference

12 December 2020

TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways

1 reference

12 December 2020

FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death--inducing signaling complex

1 reference

12 December 2020

TRAF2-mediated activation of NF-kappa B by TNF receptor 2 and CD40

1 reference

12 December 2020

Crystal structure of the soluble human 55 kd TNF receptor-human TNF beta complex: implications for TNF receptor activation

1 reference

12 December 2020

Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death

1 reference

12 December 2020

Identification of two types of tumor necrosis factor receptors on human cell lines by monoclonal antibodies

1 reference

12 December 2020

An endotoxin-induced serum factor that causes necrosis of tumors

1 reference

12 December 2020

Mechanism of cis-diamminedichloroplatinum(II)-induced cytotoxicity: role of G2 arrest and DNA double-strand breaks

1 reference

12 December 2020

Preparations of lymphotoxin induce resistance to their own cytotoxic effect

1 reference

12 December 2020

Ligand passing: the 75-kDa tumor necrosis factor (TNF) receptor recruits TNF for signaling by the 55-kDa TNF receptor.

1 reference

12 December 2020

The two different receptors for tumor necrosis factor mediate distinct cellular responses

1 reference

12 December 2020

TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB

1 reference

12 December 2020

An essential role for NF-kappaB in preventing TNF-alpha-induced cell death

1 reference

12 December 2020

Augmentation of antitumor efficacy by the combination of recombinant tumor necrosis factor and chemotherapeutic agents in vivo

1 reference

12 December 2020

Both TNF receptors are required for TNF-mediated induction of apoptosis in PC60 cells.

1 reference

12 December 2020

Recombinant human tumor necrosis factor-alpha: effects on proliferation of normal and transformed cells in vitro.

1 reference

12 December 2020

Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-kappaB activation prevents cell death

1 reference

12 December 2020

Induction of manganous superoxide dismutase by tumor necrosis factor: possible protective mechanism

1 reference

12 December 2020

A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V

1 reference

12 December 2020

Stereotactic radiosurgery for recurrent malignant gliomas

1 reference

12 December 2020

In vitro modulation of cisplatin resistance by cytokines

1 reference

12 December 2020

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

1 reference

12 December 2020

Differential roles of two types of the TNF receptor in TNF-induced cytotoxicity, DNA fragmentation, and differentiation.

1 reference

12 December 2020

Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6

1 reference

12 December 2020

RIP: a novel protein containing a death domain that interacts with Fas/APO-1 (CD95) in yeast and causes cell death

1 reference

12 December 2020

Identification of a 60-kD tumor necrosis factor (TNF) receptor as the major signal transducing component in TNF responses

1 reference

12 December 2020

Current concepts in cancer: brain tumors

1 reference

12 December 2020

Phase II clinical trial of high-dose recombinant human tumor necrosis factor

1 reference

12 December 2020

Differences in susceptibility to tumor necrosis factor alpha-induced apoptosis among MCF-7 breast cancer cell variants.

1 reference

12 December 2020

Prognostic significance of Ki-67 labeling indices obtained using MIB-1 monoclonal antibody in patients with supratentorial astrocytomas.

1 reference

12 December 2020

Molecular cloning and expression of the human 55 kd tumor necrosis factor receptor

1 reference

12 December 2020

Synergistic enhancement by tumor necrosis factor of in vitro cytotoxicity from chemotherapeutic drugs targeted at DNA topoisomerase II.

1 reference

12 December 2020

Aspartate-based inhibitor of interleukin-1 beta-converting enzyme prevents antitumor agent-induced apoptosis in human myeloid leukemia U937 cells

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1010685110862

1 reference

23 May 2018

Dimensions Publication ID

1025670745

0 references

1 reference

23 May 2018